MetLife is a stable insurance compounder with new Frontier strategy targeting capital-light growth. Group Benefits segment growing on US employer demand. Pension risk transfer (PRT) pipeline robust. Limited near-term re-rating catalysts.
Thesis reviewed May 29, 2026
MetLife, Inc. is headquartered in United States, which is currently showing moderate signals.
πΊπΈUnited States70REDUCEView United States risk detail βπ¦Financials100NEUTRAL| Ticker | Company | Score | Gap | Signal Ξ | Action |
|---|---|---|---|---|---|
| GGAL | Grupo Financiero Galicia S.A. | 90 | +13% | β58% | ENTRY |
| MELI | MercadoLibre | 90 | -14% | β58% | AVOID |
| BBAR | BBVA Banco BBVA Argentina SA | 90 | +21% | β58% | ENTRY |
| BBD | Banco Bradesco S.A. (preferred ADR) | 90 | +5% | β58% | NEUTRAL |
| VIV | Telefonica Brasil (Vivo) | 90 | +8% | β58% | ENTRY |
| UBS | UBS Group AG | 90 | +17% | β58% | ENTRY |
| CIB | Bancolombia S.A. | 90 | +9% | β58% | NEUTRAL |
Investors who hold MET may also have indirect exposure through these country funds.
MetLife Q1 2026 adjusted EPS +5% YoY; PRT volumes record
Estimates Β· Yahoo Finance Β· Not audited figures
| Politician | Party | Type | Amount | Trade Date | Return |
|---|---|---|---|---|---|
| Alan Armstrong | Buy | $1kβ$15k | Mar 27, 26 | ||
| Sheldon Whitehouse | Sell | $1kβ$15k | Nov 19, 24 | +0.6% |